CVSS was commissioned by the National Infrastructure Advisory Council (NIAC) tasked in support of the global Vulnerability Disclosure Framework. It is currently maintained by FIRST (Forum of Incident Response and Security Teams) http://www.first.org/. CVSS was a joint effort involving many groups including: Since the original release of CVSS, additional groups have joined the CVSS effort and assisted in developing version 2 of CVSS. The current list of major participants is available at www.

CVSS stands for The Common Vulnerability Scoring System and is a vendor agnostic, industry open standard designed to convey vulnerability severity and help determine urgency and priority of response. It solves the problem of multiple, incompatible scoring systems and is usable and understandable by anyone.

The CVSS model is designed to provide the end user with an overall composite score representing the severity and risk of a vulnerability. It is derived from metrics and formulas. The metrics are in three distinct categories that can be quantitatively or qualitatively measured. Base Metrics contain qualities that are intrinsic to any given vulnerability that do not change over time or in different environments.

There are many sources of CVSS scores. Several major sources of CVSS scores are posted at http://www.first.org/cvss/scores.html.

CVSS is a framework that you can use to develop an application suitable to your needs, your environment or your customers. There is no established code as of yet. However, there are several CVSS calculators available; a listing of some calculators is posted at http://www.first.org/cvss/scores.html.

The current version of CVSS is version 2. It was finalized and released to the public in June 2007. This FAQ addresses CVSS version 2 only, although there are many similarities between versions 1 and 2. Information on CVSS version 1 is available from the NIAC Paper on CVSS at http://www.first.org/cvss/cvss-dhs-12-02-04.pdf.

Where can I get more information on CVSS?A: You can get more information at FIRST, the current custodian for CVSS at http://www.first.org/cvss. Documentation on CVSS metrics, formulas, and scoring is available at http://www.first.org/cvss/cvss-guide.html.

An open framework that can be used, understood, and improved upon by anybody to score vulnerabilities.

A: You can get more information at FIRST, the current custodian for CVSS at http://www.first.org/cvss/. Documentation on CVSS metrics, formulas, and scoring is available a http://www.first.org/cvss/cvss-guide.html.

SBML originated out of a workshop on software platforms for systems biology held in the year 2000 with funding by the Japan Science and Technology Corporation (JST). The original authors were Michael Hucka, Andrew Finney, Herbert Sauro and Hamid Bolouri, but SBML is now very much a community effort. Please see Section 8 for more details about the history of SBML. See Section 7 about how you can participate in SBML's evolution.

Explore all the courses offered by visiting our course catalogue or join our email list to hear about the latest course offerings. Botanicals and Women's Health 2 is in development. Note: Botanicals and Health: Foundations is a pre-requisite for all future botanicals courses.

In 1983, Dr. Gail Smith from the University of Pennsylvania School of Veterinary Medicine began to research and develop a scientific method for the early diagnosis of CHD. Multiple scientific disciplines - including biomechanics, orthopedics, clinical medicine, radiology, epidemiology and population genetics - have been incorporated during the development of PennHIP.

NCS developed the NDAC because of heavy NS/EP reliance on the PSN. The NDAC works to model natural and man-made disruptions to the PSN and enables the NCS to perform vendor independent analyses, develop models and methodologies to identify vulnerabilities and congestion, identify critical infrastructures’ dependence on telecommunications, and identify network effectiveness solutions.

MoleMapCD technology was developed in conjunction with the Duke University Comprehensive Cancer Center in Durham, N.C. by Jim Grichnik, MD, PhD, a nationally-recognized melanoma researcher and clinician. Dr. Grichnik has used the technology at Duke for over 10 years.

Following the success of the Trienelle skincare line for aging skin, Dr. Wilkinson turned his attention to acne. Both of his children have acne in their late 20’s – having started back in their early teens. And, having tried most of the different OTC and prescription treatments, still struggled. with the Trienelle products, Dr. Wilkinson collaborated with Dr. Ron DiSalvo and Dr. Jeane Huang for the acne treatment system. Dr.

MetaL is not just yet another language. It is a meta-language which means that it can generate automatically programs in traditional languages, eventually for tasks that are tedious or take too much work to write code manually. Therefore, MetaL is not intended to be a competitor of traditional languages but rather a complement that can be used to increase the productivity of software developers.

The original essences, which were mostly made from flowers, were developed by Dr. Edward Bach (1886-1936), an English physician who gave up his busy practice to study and prepare the 38 flower essences (plus the 5-flower combination, Rescue Remedy) now known as Bach Flower Remedies or English Flower Essences. Dr. Bach was a physician and homeopath before discovering the energetic basis of illness and distress. He dedicated his life to creating this simple, effective, safe system of healing.

Very few people would be able to get vaccinated at first. If a pandemic occurs, federal, state and local governments will work with partner groups to make specific recommendations on the early use of vaccine. Current recommendations are to target limited vaccine supplies to people at high risk and healthcare workers.

The Closure technology and procedure were developed over a four year period by a team of medical engineers, in association with a Silicon Valley physician inventor with more than 125 patents.

SPECjAppServer2004 was developed by the Java subcommittee's core design team. BEA, Borland, Darmstadt University of Technology, HP, IBM, Intel, Oracle, Pramati, Sun and Sybase participated in design, implementation and testing phases of the product. SPECjAppServer2004 is not a refresh of the older SPECjAppServer (01,02) benchmarks. In addition to the EJB tier exercised in older SPECjAppServer benchmarks, SPECjAppServer2004 also extensively exercises the web tier and the messaging infrastructure.

BetaCell? daily oral rinse was developed based on results of two clinical trial at a leading California Research Institute. The trials were based on the treatment of Oral Leukoplakia.